Number of the records: 1
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors
- 1.Plašilová, M., Živný, J., Jelínek, J., Neuwirtová, R., Čermák, J., Nečas, E., Anděra, L., Stopka, T. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia. 2002, 16(1), 67-73. ISSN 0887-6924. E-ISSN 1476-5551.
Number of the records: 1